Description

KPV represents a synthetic tripeptide consisting of lysine-proline-valine, derived from the C-terminal region of α-melanocyte stimulating hormone and demonstrating potent anti-inflammatory properties in research models. The compound functions through melanocortin receptor-independent mechanisms, providing anti-inflammatory effects without the pigmentation and other effects associated with full melanocortin receptor activation. KPV has been studied for its ability to reduce inflammatory responses, modulate immune cell function, and provide protection against inflammatory damage in various research applications. The peptide demonstrates activity in multiple inflammatory models and has been investigated for its effects on cytokine production, immune cell activation, and inflammatory signaling pathways. Research applications include investigation of anti-inflammatory mechanisms, immune regulation pathways, inflammatory disease models, and the development of anti-inflammatory strategies for research purposes. For research use only.